Prediction of ischemic stroke in patients with H-type hypertension based on biomarker

Abstract Hypertension combined with hyperhomocysteinemia significantly raises the risk of ischemic stroke. Our study aimed to develop and validate a biomarker-based prediction model for ischemic stroke in Hyperhomocysteinemia-type (H-type) hypertension patients. We retrospectively included 3,305 pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Ke Chen, Jianxun He, Lan Fu, Xiaohua Song, Ning Cao, Hui Yuan
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-83662-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544858662076416
author Ke Chen
Jianxun He
Lan Fu
Xiaohua Song
Ning Cao
Hui Yuan
author_facet Ke Chen
Jianxun He
Lan Fu
Xiaohua Song
Ning Cao
Hui Yuan
author_sort Ke Chen
collection DOAJ
description Abstract Hypertension combined with hyperhomocysteinemia significantly raises the risk of ischemic stroke. Our study aimed to develop and validate a biomarker-based prediction model for ischemic stroke in Hyperhomocysteinemia-type (H-type) hypertension patients. We retrospectively included 3,305 patients in the development cohort, and externally validated in 103 patients from another cohort. Logistic regression, least absolute shrinkage and selection operator regression, and best subset selection analysis were used to assess the contribution of variables to ischemic stroke, and models were derived using four machine learning algorithms. Area Under Curve (AUC), calibration plot and decision-curve analysis respectively evaluated the discrimination and calibration of four models, then external validation and visualization of the best-performing model. There were 1,415 and 42 patients with ischemic stroke in the development and validation cohorts. The final model included 8 predictors: age, antihypertensive therapy, biomarkers (serum magnesium, serum potassium, proteinuria and hypersensitive C-reactive protein), and comorbidities (atrial fibrillation and hyperlipidemia). The optimal model, named A2BC ischemic stroke model, showed good discrimination and calibration ability for ischemic stroke with AUC of 0.91 and 0.87 in the internal and external validation cohorts. The A2BC ischemic stroke model had satisfactory predictive performances to assist clinicians in accurately identifying the risk of ischemic stroke for patients with H-type hypertension.
format Article
id doaj-art-f7acffc8bab74a1399c5d117198b9c71
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-f7acffc8bab74a1399c5d117198b9c712025-01-12T12:16:32ZengNature PortfolioScientific Reports2045-23222025-01-0115111010.1038/s41598-024-83662-3Prediction of ischemic stroke in patients with H-type hypertension based on biomarkerKe Chen0Jianxun He1Lan Fu2Xiaohua Song3Ning Cao4Hui Yuan5Department of Clinical Laboratory, Beijing Anzhen Hospital, Capital Medical UniversityDepartment of Clinical Laboratory, Beijing Anzhen Hospital, Capital Medical UniversityPhysical Examination Center, Beijing Anzhen Hospital, Capital Medical UniversityPhysical Examination Center, Beijing Anzhen Hospital, Capital Medical UniversityDepartment of Clinical Laboratory, China-Japan Friendship HospitalDepartment of Clinical Laboratory, Beijing Anzhen Hospital, Capital Medical UniversityAbstract Hypertension combined with hyperhomocysteinemia significantly raises the risk of ischemic stroke. Our study aimed to develop and validate a biomarker-based prediction model for ischemic stroke in Hyperhomocysteinemia-type (H-type) hypertension patients. We retrospectively included 3,305 patients in the development cohort, and externally validated in 103 patients from another cohort. Logistic regression, least absolute shrinkage and selection operator regression, and best subset selection analysis were used to assess the contribution of variables to ischemic stroke, and models were derived using four machine learning algorithms. Area Under Curve (AUC), calibration plot and decision-curve analysis respectively evaluated the discrimination and calibration of four models, then external validation and visualization of the best-performing model. There were 1,415 and 42 patients with ischemic stroke in the development and validation cohorts. The final model included 8 predictors: age, antihypertensive therapy, biomarkers (serum magnesium, serum potassium, proteinuria and hypersensitive C-reactive protein), and comorbidities (atrial fibrillation and hyperlipidemia). The optimal model, named A2BC ischemic stroke model, showed good discrimination and calibration ability for ischemic stroke with AUC of 0.91 and 0.87 in the internal and external validation cohorts. The A2BC ischemic stroke model had satisfactory predictive performances to assist clinicians in accurately identifying the risk of ischemic stroke for patients with H-type hypertension.https://doi.org/10.1038/s41598-024-83662-3H-type hypertensionIschemic strokePrediction model
spellingShingle Ke Chen
Jianxun He
Lan Fu
Xiaohua Song
Ning Cao
Hui Yuan
Prediction of ischemic stroke in patients with H-type hypertension based on biomarker
Scientific Reports
H-type hypertension
Ischemic stroke
Prediction model
title Prediction of ischemic stroke in patients with H-type hypertension based on biomarker
title_full Prediction of ischemic stroke in patients with H-type hypertension based on biomarker
title_fullStr Prediction of ischemic stroke in patients with H-type hypertension based on biomarker
title_full_unstemmed Prediction of ischemic stroke in patients with H-type hypertension based on biomarker
title_short Prediction of ischemic stroke in patients with H-type hypertension based on biomarker
title_sort prediction of ischemic stroke in patients with h type hypertension based on biomarker
topic H-type hypertension
Ischemic stroke
Prediction model
url https://doi.org/10.1038/s41598-024-83662-3
work_keys_str_mv AT kechen predictionofischemicstrokeinpatientswithhtypehypertensionbasedonbiomarker
AT jianxunhe predictionofischemicstrokeinpatientswithhtypehypertensionbasedonbiomarker
AT lanfu predictionofischemicstrokeinpatientswithhtypehypertensionbasedonbiomarker
AT xiaohuasong predictionofischemicstrokeinpatientswithhtypehypertensionbasedonbiomarker
AT ningcao predictionofischemicstrokeinpatientswithhtypehypertensionbasedonbiomarker
AT huiyuan predictionofischemicstrokeinpatientswithhtypehypertensionbasedonbiomarker